FDA Approves " Follow-On " Human Insulin Product to Treat Diabetes

Another short-acting insulin lispro injection has been approved by the FDA to treat adults and children with diabetes. The drug, marketed as Admelog, is...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news